Witte, M., Dugger, B., Serrano, G., Bedell, B. J., Doraiswamy, P. M., Fleisher, A. S., … Beach, T. G. (2013). Florbetapir PET Imaging Predicts Postmortem Amyloid Burden in Alzheimer's Disease Despite Presence of Other Neuropathologies. In The American Journal of Geriatric Psychiatry (Vol. 21, pp. S138–S139). Elsevier BV. https://doi.org/10.1016/j.jagp.2012.12.183

Witte, Michael, Brittany Dugger, Geidy Serrano, Barry J. Bedell, P Murali Doraiswamy, Adam S. Fleisher, Eric Reiman, et al. “Florbetapir PET Imaging Predicts Postmortem Amyloid Burden in Alzheimer's Disease Despite Presence of Other Neuropathologies.” In The American Journal of Geriatric Psychiatry, 21:S138–39. Elsevier BV, 2013. https://doi.org/10.1016/j.jagp.2012.12.183.

Witte M, Dugger B, Serrano G, Bedell BJ, Doraiswamy PM, Fleisher AS, et al. Florbetapir PET Imaging Predicts Postmortem Amyloid Burden in Alzheimer's Disease Despite Presence of Other Neuropathologies. In: The American Journal of Geriatric Psychiatry. Elsevier BV; 2013. p. S138–9.

Witte, Michael, et al. “Florbetapir PET Imaging Predicts Postmortem Amyloid Burden in Alzheimer's Disease Despite Presence of Other Neuropathologies.” The American Journal of Geriatric Psychiatry, vol. 21, no. 3, Elsevier BV, 2013, pp. S138–39. Crossref, doi:10.1016/j.jagp.2012.12.183.

Witte M, Dugger B, Serrano G, Bedell BJ, Doraiswamy PM, Fleisher AS, Reiman E, Sabbagh MN, Sadowsky CH, Schneider JA, Carpenter AP, Joshi AD, Mintun MA, Pontecorvo MJ, Skovronsky DM, Sue LI, Beach TG. Florbetapir PET Imaging Predicts Postmortem Amyloid Burden in Alzheimer's Disease Despite Presence of Other Neuropathologies. The American Journal of Geriatric Psychiatry. Elsevier BV; 2013. p. S138–S139.